TOM1L1
Basic information
Region (hg38): 17:54899387-54961956
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (60 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TOM1L1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000005486.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 0 | |||||
| missense | 58 | 60 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 58 | 2 | 0 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| TOM1L1 | protein_coding | protein_coding | ENST00000575882 | 15 | 62563 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 4.60e-10 | 0.810 | 125649 | 1 | 98 | 125748 | 0.000394 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.298 | 236 | 249 | 0.947 | 0.0000117 | 3155 |
| Missense in Polyphen | 82 | 83.869 | 0.97771 | 1162 | ||
| Synonymous | 1.70 | 69 | 89.5 | 0.771 | 0.00000456 | 875 |
| Loss of Function | 1.64 | 19 | 28.4 | 0.669 | 0.00000139 | 338 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000992 | 0.000930 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000657 | 0.000653 |
| Finnish | 0.0000928 | 0.0000924 |
| European (Non-Finnish) | 0.000393 | 0.000387 |
| Middle Eastern | 0.000657 | 0.000653 |
| South Asian | 0.000528 | 0.000523 |
| Other | 0.000495 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Probable adapter protein involved in signaling pathways. Interacts with the SH2 and SH3 domains of various signaling proteins when it is phosphorylated. May promote FYN activation, possibly by disrupting intramolecular SH3-dependent interactions (By similarity). {ECO:0000250}.;
- Pathway
- EGFR1
(Consensus)
Recessive Scores
- pRec
- 0.0938
Intolerance Scores
- loftool
- 0.914
- rvis_EVS
- -0.69
- rvis_percentile_EVS
- 15.12
Haploinsufficiency Scores
- pHI
- 0.209
- hipred
- Y
- hipred_score
- 0.542
- ghis
- 0.532
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.643
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tom1l1
- Phenotype
Gene ontology
- Biological process
- intracellular protein transport;signal transduction;positive regulation of protein autophosphorylation;activation of protein kinase activity;ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;negative regulation of mitotic nuclear division;regulation of DNA biosynthetic process
- Cellular component
- cytoplasm;lysosome;endosome;Golgi stack;cytosol;endosome membrane;extracellular exosome
- Molecular function
- protein binding;SH3 domain binding;protein kinase binding;clathrin binding;protein kinase activator activity;ubiquitin binding